Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index <55%: single-arm phase II study

BACKGROUND: Grade 3 neuroendocrine neoplasms (NENs) of gastroenteropancreatic (GEP) origin with Ki-67 indices <55% do not respond well to platinum-based chemotherapy. The combination of capecitabine and temozolomide (CAPTEM) has shown favorable responses in grade 1-2 NENs, but has rarely been stu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:ESMO Open
Hoofdauteurs: Jeong, H., Shin, J., Jeong, J.H., Kim, K.-p., Hong, S.-M., Kim, Y.-i., Ryu, J.-S., Ryoo, B.-Y., Yoo, C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2021
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099746/
https://ncbi.nlm.nih.gov/pubmed/33901869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100119
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items